, /PRNewswire/ -- The global breast tissue expander market size is estimated to grow by from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 6.78% during the forecast period.
Increasing prevalence of breast cancer is driving market growth, with a trend towards growing awareness programs for breast cancer. However, high costs associated with breast reconstruction surgeries poses a challenge. Key market players include AbbVie Inc.
, Establishment Labs Holdings Inc., Global Consolidated Aesthetics Ltd., Groupe SEBBIN SAS, Guangzhou Wanhe Plastic Materials Co.
Ltd., Johnson and Johnson Services Inc., PMT Corp.
, POLYTECH Health and Aesthetics GmbH, Sientra Inc., Silimed Industria de Implantes Ltd., and Specialty Surgical Products Inc.
. Get a detailed analysis on regions, market segments, customer landscape, and companies- The global breast tissue expander market is witnessing growth due to the rising incidence of breast cancer and associated risk factors. Notable risk factors include genetic mutations, reproductive history, previous radiation therapy, alcohol consumption, and hormone intake.
In response, various organizations are promoting education and awareness programs, as well as offering breast screening facilities for early detection. For instance, the Department of Health in operates the BreastScreen Australia program, which invites women aged between 50 and 74 for free mammograms every two years. The government plans to invest to extend this .
